Stay updated on Nivolumab/Daratumumab in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab/Daratumumab in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab/Daratumumab in Multiple Myeloma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2, and the previous government funding notice (the lapse notice with related guidance) has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T11:36:12.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Introduced a site-wide notice regarding a lapse in government funding and updated operating status information for the NIH Clinical Center. The page footer revision changed from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-04T05:57:36.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    UI updates include adding a glossary display and updating last-update fields (Last Update Submitted that Met QC Criteria, Last Update Posted) along with the page revision to v3.4.0. The previous v3.3.4 revision and the (Estimated) Last Update Posted tag were removed, and No FEAR Act data labeling was adjusted.
    Difference
    0.2%
    Check dated 2026-01-28T04:17:56.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page indicates a minor version update from v3.3.3 to v3.3.4 with no apparent changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:06:34.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The Contacts and Locations section was updated to add multiple new sites across the US (including California, Colorado, Connecticut, Florida, Illinois, Indiana, Kansas, Maryland, Massachusetts, Michigan, Minnesota, Nebraska, New Jersey, New York, Ohio, Oregon, Pennsylvania, Utah) and a location in Vienne, while removing several existing entries; this reflects updated site availability and contact points for potential participants.
    Difference
    1%
    Check dated 2025-12-23T17:35:25.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    PubMed publications note updated to indicate automatic filling from PubMed and Revision: v3.3.2; the previous PubMed note and Revision: v3.2.0 were removed.
    Difference
    0.1%
    Check dated 2025-11-24T21:45:09.000Z thumbnail image

Stay in the know with updates to Nivolumab/Daratumumab in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab/Daratumumab in Multiple Myeloma Clinical Trial page.